Nature Reviews Drug Discovery 14, 225–226 (2015)
Table 1 on page 226 described mocetinostat as an inhibitor of class I histone deacetylases (HDACs). It is also an inhibitor of HDAC11, which is in class IV. This has been corrected in the online version.
Additional information
The online version of the original article can be found at 10.1038/nrd4583
Rights and permissions
About this article
Cite this article
Guha, M. Erratum: HDAC inhibitors still need a home run, despite recent approval. Nat Rev Drug Discov 14, 365 (2015). https://doi.org/10.1038/nrd4632
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd4632
